Rabies vaccine (IBSS Biomed)

Rabies vaccine (adsorbed) is an inactivated viral vaccine developed and manufactured by IBSS Biomed (Biomed Kraków) for human use. It is indicated for both pre-exposure prophylaxis (PrEP) in individuals at high risk of rabies virus contact and post-exposure prophylaxis (PEP) following potential exposure. The vaccine contains the Pitman-Moore (PM) strain of the rabies virus, which has been inactivated and adsorbed onto an aluminum hydroxide adjuvant to enhance immunogenicity. Upon administration, the vaccine stimulates the production of neutralizing antibodies and elicits a cellular immune response, providing protection against the fatal encephalomyelitis caused by the rabies virus. It is an approved product in Poland and is typically administered via intramuscular injection.

Other names

Rabies vaccine (adsorbed)Szczepionka przeciw wściekliźnie adsorbowana